TY - JOUR
T1 - α-Synuclein Negatively Regulates Nurr1 Expression Through NF-κB-Related Mechanism
AU - Jia, Congcong
AU - Qi, Hongqian
AU - Cheng, Cheng
AU - Wu, Xuefei
AU - Yang, Zhaofei
AU - Cai, Huaibin
AU - Chen, Sheng
AU - Le, Weidong
N1 - Funding Information:
This work was supported by the National Nature Science Foundation of China (NSFC81430021, 81771521) and Key Research and Development Plan of Liaoning Science and Technology Department (2018225051).
Publisher Copyright:
© Copyright © 2020 Jia, Qi, Cheng, Wu, Yang, Cai, Chen and Le.
PY - 2020/5/12
Y1 - 2020/5/12
N2 - The nuclear receptor-related 1 protein (Nurr1) is critical for the development and survival of midbrain dopamine neurons that are predominantly affected and progressively degenerated in Parkinson’s disease (PD). The expression level of Nurr1 has been proposed to be modulated by α-synuclein (α-SYN), an important pathological hallmark of PD. However, the underlying molecular mechanisms of α-SYN-Nurr1 interaction are still rarely explored. In this study, we investigated the effect and mechanism of α-SYN on the transcription level of Nurr1. Our results showed that overexpression of α-SYN (WT or A53T) reduced Nurr1 and its downstream gene expressions. α-SYN neither affected the mRNA stability nor bound with the promoter of Nurr1, but modulated the transcription activity of Nurr1 promoter region ranging from −605 bp to −418 bp, which contains the binding site of nuclear factor-kappa B (NF-κB). Moreover, overexpression of α-SYN (WT or A53T) down-regulated NF-κB expression level, thereby inhibiting the transcription factor activity of NF-κB and decreasing the binding quantity of NF-κB with Nurr1 promoter. These findings may give us new insights to better understand the molecular mechanisms underlying the α-SYN-regulated Nurr1 function, which may fascinate the investigation of dopamine neuron degeneration in PD pathogenesis.
AB - The nuclear receptor-related 1 protein (Nurr1) is critical for the development and survival of midbrain dopamine neurons that are predominantly affected and progressively degenerated in Parkinson’s disease (PD). The expression level of Nurr1 has been proposed to be modulated by α-synuclein (α-SYN), an important pathological hallmark of PD. However, the underlying molecular mechanisms of α-SYN-Nurr1 interaction are still rarely explored. In this study, we investigated the effect and mechanism of α-SYN on the transcription level of Nurr1. Our results showed that overexpression of α-SYN (WT or A53T) reduced Nurr1 and its downstream gene expressions. α-SYN neither affected the mRNA stability nor bound with the promoter of Nurr1, but modulated the transcription activity of Nurr1 promoter region ranging from −605 bp to −418 bp, which contains the binding site of nuclear factor-kappa B (NF-κB). Moreover, overexpression of α-SYN (WT or A53T) down-regulated NF-κB expression level, thereby inhibiting the transcription factor activity of NF-κB and decreasing the binding quantity of NF-κB with Nurr1 promoter. These findings may give us new insights to better understand the molecular mechanisms underlying the α-SYN-regulated Nurr1 function, which may fascinate the investigation of dopamine neuron degeneration in PD pathogenesis.
KW - Parkinson’s disease
KW - dopamine
KW - nuclear factor κ B (NF-κB)
KW - nuclear receptor-related 1 protein (Nurr1)
KW - α-synuclein
UR - http://www.scopus.com/inward/record.url?scp=85087548989&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85087548989&partnerID=8YFLogxK
U2 - 10.3389/fnmol.2020.00064
DO - 10.3389/fnmol.2020.00064
M3 - Article
AN - SCOPUS:85087548989
VL - 13
JO - Frontiers in Molecular Neuroscience
JF - Frontiers in Molecular Neuroscience
SN - 1662-5099
M1 - 64
ER -